Exact FDA event identifier

Event 61624

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: April 17, 2012
Product types: Drug
Classifications: Class I
Statuses: Terminated
Recalling firm wording: Hospira Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Morphine Sulfate Injection, USP, 4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartridge Unit with Luer Lock, packaged 10 Carpujects/carton, CII, Rx only, Hospira, Inc., Lake Forest, IL ---- NDC 0409-1258-30

D-1419-2012

Recall number: D-1419-2012
Initiated: April 17, 2012
Classification: Class I
Status: Terminated
Recalling firm: Hospira Inc.
Quantity: 212,370 cartidges

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Superpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL

Code information

Lot #10830LL, Exp. 1APR2013

Distribution pattern

Nationwide